Johnson & Johnson (JNJ) Aktie Kurs
Johnson & Johnson Kurs
De seneste 19 år voksede Johnson & Johnsons omsætning med 3,0 % årligt og nåede 94,19 Mrd. USD. Indtjening pr. aktie er vokset med 5,8 % om året de seneste 19 år. For Johnson & Johnson er nettoavance på 28,5 % op i forhold til 26,5 % for et par år siden. Ved dagens kurs bliver direkteafkastet cirka 1,91 %. Udlodningsandelen er omkring 47 % af indtjeningen. Udbyttet er vokset med 6,9 % om året de seneste 19 år. Konsensus 12-måneders kursmål for Johnson & Johnson er 282,00 USD, cirka over kursen med 5,0 %. Af 30 analytikere anbefaler 21 køb — den samlede vurdering er Køb.
Johnson & Johnson aktiekurs
Hent disse data via Eulerpool API
100.000 requests/md. gratis · intet kreditkort
Johnson & Johnson aktie og aktieanalyse
Hyppigt stillede spørgsmål om Johnson & Johnson-aktien
Johnson & Johnson operates under a diversified business model. The company is engaged in the development, manufacturing, and marketing of a wide range of healthcare products. Their business segments include pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for their innovative approach in creating advanced treatments and solutions for various health conditions and diseases. With a focus on research and development, they strive to provide high-quality products that improve the well-being of people around the world. Johnson & Johnson's commitment to delivering value to their customers and stakeholders drives their success in the global healthcare industry.
Johnson & Johnson is primarily active in the healthcare industry. With a diverse range of products, the company operates in multiple sectors such as pharmaceuticals, medical devices, and consumer health. Johnson & Johnson is renowned for its comprehensive portfolio that includes prescription drugs, over-the-counter medications, surgical equipment, contact lenses, and personal care products. Being a global leader, Johnson & Johnson's presence extends across various healthcare segments, enabling it to contribute significantly to advancing medical solutions and enhancing overall well-being.
Some of the main competitors of Johnson & Johnson in the market include Pfizer Inc., Merck & Co., Inc., and Roche Holding AG.
Johnson & Johnson is a multinational healthcare company that was founded in 1886. It has a rich history and has become a leader in the pharmaceutical, medical devices, and consumer healthcare sectors. With over 130 years of experience, Johnson & Johnson has continually focused on delivering innovative solutions to improve the health and well-being of people around the world. The company has grown through strategic acquisitions and partnerships, expanding its product portfolio and global presence. Johnson & Johnson's commitment to research and development, along with its dedication to ethical business practices, have made it a trusted name in the healthcare industry.
Some significant milestones achieved by Johnson & Johnson include the development of innovative medical treatments and breakthrough pharmaceutical products. Throughout its history, the company has also played a crucial role in the advancement of healthcare technology and the improvement of patient care. Johnson & Johnson has consistently demonstrated its commitment to quality and safety, earning a reputation as a trusted global healthcare leader. With a strong focus on research and development, the company has introduced numerous life-saving and life-enhancing solutions to address a wide range of medical needs. Through its dedication to innovation and excellence, Johnson & Johnson continues to shape the future of healthcare.
Johnson & Johnson is primarily present in several countries and regions worldwide. The company has a significant presence in the United States, where it is headquartered, and it operates in countries across North America, Europe, Asia Pacific, and Latin America. Some prominent regions where Johnson & Johnson operates include Canada, Germany, France, Japan, Australia, Brazil, and China. With its diverse portfolio of healthcare products and services, Johnson & Johnson continues to expand its presence globally, serving the healthcare needs of people in numerous countries and regions.
Johnson & Johnson is a renowned global healthcare company that upholds strong values and a clear corporate philosophy. With a commitment to improving the well-being of people worldwide, the company focuses on three fundamental principles: caring for the world, keeping customers at the center, and cherishing employees. Johnson & Johnson values integrity, innovation, diversity, and collaboration, consistently striving to deliver high-quality products and solutions. With a customer-centric approach, the company endeavors to create lasting relationships and enhance experiences. By fostering a supportive work environment and promoting professional growth, Johnson & Johnson ensures its employees play a vital role in achieving its mission.
Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 282,08 USD for Johnson & Johnson-aktien (median: 282,00 USD), svarende til +3,5 % i forhold til seneste kurs. Konsensus bygger på 30 analytikervurderinger.
30 analytikere vurderer i øjeblikket Johnson & Johnson-aktien: 21 anbefaler køb, 9 hold og 0 salg. For 2026 forventer analytikere, at Johnson & Johnson genererer omsætning på 101,21 Mrd. USD og indtjening pr. aktie på 11,07 USD.
Omregnet til den aktuelle valutakurs handles Johnson & Johnson-aktien til 239,83 EUR (268,48 USD).
Johnson & Johnson-aktien (JNJ) er noteret på 12 børser, herunder: NYSE (JNJ), London (0R34.L), SIX (Zürich) (JNJUSD.SW), XETRA (JNJ.DE), Frankfurt (JNJ.F), München (JNJ.MU), Stuttgart (JNJ.SG), Düsseldorf (JNJ.DU).
Johnson & Johnson is one of the largest healthcare companies in the world. The company was founded in 1886 and is based in New Brunswick, New Jersey. With a wide portfolio of products and services, Johnson & Johnson is active in the consumer goods, medical technology, and pharmaceutical sectors. Consumer Goods: Johnson & Johnson is best known for its baby care products, such as diapers and wipes. The company also offers a wide range of other products, including personal care, wound healing, and pain relief products. Medical Technology: As a global leader in medical devices and instruments, Johnson & Johnson provides solutions for various areas of the medical field. In orthopedics, for example, the company offers implants for a variety of joints and bones. In medical imaging, Johnson & Johnson has a diverse range of devices that can be used for diagnosis and treatment. Pharmaceuticals: Johnson & Johnson is also active in the pharmaceutical business. The company is a global leader in the development and marketing of prescription drugs. In the field of oncology, for example, Johnson & Johnson offers various medications for the treatment of cancer. The company is also involved in neurology and immunology, offering a wide range of medications. Innovative Technologies: Johnson & Johnson heavily invests in innovative technologies to improve treatment options for patients. Examples of this include the "CaringCrowd" crowdfunding platform and the "Janssen Health EMEA Innovation Center," a platform for start-ups and companies focusing on groundbreaking innovations in healthcare. Research and Development: Research and development is a crucial aspect of Johnson & Johnson's business success. The company invests significant amounts each year in the research and development of new products and technologies. The goal is to develop products that meet the needs of patients and address various diseases and conditions. Johnson & Johnson also conducts extensive clinical studies to ensure the safety and efficacy of its products. Conclusion: Johnson & Johnson has a diverse range of products and services. The company is a leading provider in consumer goods, medical technology, and pharmaceuticals. It heavily invests in innovative technologies and research and development to offer treatment options to patients worldwide that meet the highest standards in terms of efficacy and safety. The output answer: Johnson & Johnson is a global healthcare company that offers a wide range of consumer goods, medical technology, and pharmaceutical products. It invests in innovative technologies and research and development to provide effective and safe treatment options for patients worldwide.
forventet-omsætningen for Johnson & Johnson er 101,21 Mrd. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.
forventet-overskuddet for Johnson & Johnson er 26,99 Mrd. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.
Pris-til-indtjening-forholdet (P/E) for Johnson & Johnson er i øjeblikket 24,26. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Johnson & Johnson-aktien.
Pris-til-salgs-forholdet (P/S) for Johnson & Johnson er i øjeblikket 6,47. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Johnson & Johnson-aktien.
AlleAktien-kvalitetsscore for Johnson & Johnson er 7/10.
ISIN for Johnson & Johnson er US4781601046. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
WKN for Johnson & Johnson er 853260. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.
Tickeren for Johnson & Johnson er JNJ. Tickersymbolet bruges til at handle Johnson & Johnson-aktier på børsen.
Johnson & Johnson aktie
Johnson & Johnson Peer Group
Johnson & Johnson Ticker
Johnson & Johnson FIGI
Alle fundamentale data om Johnson & Johnson i deep dive
Vores aktieanalyse af Johnson & Johnson-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Johnson & Johnson. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: